Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
Kouyos RD, von Wyl V, Yerly S, Böni J, Taffé P, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Furrer H, Battegay M, Vernazza PL, Bernasconi E, Rickenbach M, Ledergerber B, Bonhoeffer S, Günthard HF. Kouyos RD, et al. Among authors: boni j. J Infect Dis. 2010 May 15;201(10):1488-97. doi: 10.1086/651951. J Infect Dis. 2010. PMID: 20384495 Free article.
HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.
Schüpbach J, Böni J, Bisset LR, Tomasik Z, Fischer M, Günthard HF, Ledergerber B, Opravil M; Swiss HIV Cohort Study. Schüpbach J, et al. Among authors: boni j. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):292-9. doi: 10.1097/00126334-200307010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12843739 Clinical Trial.
Prevalence of human T-cell leukemia virus types I and II in Switzerland.
Böni J, Bisset LR, Burckhardt JJ, Joller-Jemelka HI, Bürgisser P, Perrin L, Gorgievski M, Erb P, Fierz W, Piffaretti JC, Schüpbach J; Swiss HIV Cohort Study. Böni J, et al. J Med Virol. 2004 Feb;72(2):328-37. doi: 10.1002/jmv.10541. J Med Virol. 2004. PMID: 14695678
HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
Oxenius A, Price DA, Hersberger M, Schlaepfer E, Weber R, Weber M, Kundig TM, Böni J, Joller H, Phillips RE, Flepp M, Opravil M, Speck RF; Swiss HIV Cohort Study. Oxenius A, et al. Among authors: boni j. J Infect Dis. 2004 Apr 1;189(7):1199-208. doi: 10.1086/382028. Epub 2004 Mar 17. J Infect Dis. 2004. PMID: 15031788 Free article.
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
Joos B, Trkola A, Fischer M, Kuster H, Rusert P, Leemann C, Böni J, Oxenius A, Price DA, Phillips RE, Wong JK, Hirschel B, Weber R, Günthard HF; Swiss HIV Cohort Study. Joos B, et al. Among authors: boni j. J Virol. 2005 Jul;79(14):9026-37. doi: 10.1128/JVI.79.14.9026-9037.2005. J Virol. 2005. PMID: 15994796 Free PMC article.
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.
Schüpbach J, Günthard H, Joos B, Fischer M, Böni J, Tomasik Z, Yerly S, Perrin L, Battegay M, Furrer H, Vernazza P, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. Schüpbach J, et al. Among authors: boni j. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):250-6. doi: 10.1097/01.qai.0000181281.75670.56. J Acquir Immune Defic Syndr. 2005. PMID: 16249697 Clinical Trial.
491 results